Liting Lu
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
NLRC3 suppresses hepatocarcinogenesis by disrupting the HSP90-mediated TRAF6/MYC signalling activation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 07, 2026
Colon cancer cachexia remodels gut microbiota and metabolite profiles in a murine model.
Journal: Journal of gastrointestinal oncology
Published: September 05, 2025
The PDE4DIP-AKAP9 axis promotes lung cancer growth through modulation of PKA signalling.
Journal: Communications biology
Published: February 27, 2024
NLRC3 deficiency promotes cutaneous wound healing due to the inhibition of p53 signaling.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 02, 2022
Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.
Journal: Oncogene
Published: March 18, 2021
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.
Journal: Cell death & disease
Published: May 12, 2020
Non-invasive Bioluminescence Monitoring of Hepatocellular Carcinoma Therapy in an HCR Mouse Model.
Journal: Frontiers in oncology
Published: February 26, 2019
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
Journal: Nature communications
Published: September 24, 2013
Last Updated: 09/26/2026